ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123

ICG140:CD19-CD123 cCAR T-cells, a chimeric antigen receptor (CAR) on the surface of T-cells directed against the target proteins CD19 and CD 123
Trade Name
Orphan Indication Acute lymphoblastic leukemia
USA Market Approval USA
USA Designation Date 2017-12-26 00:00:00
Sponsor iCell Gene Therapeutics;25 Health Sciences Drive, Suite 118;Stony Brook, New York, 11793
Related Access Program
Novartis Pharmaceuticals – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute Lymphoblastic Leukemia ERYtech Pharma – Acute Lymphoblastic Leukemia University of California, San Francisco – Acute lymphoblastic leukemia ERYtech Pharma – Acute lymphoblastic leukemia Amgen – Acute lymphoblastic leukemia